United States · Funded startup

Who invested in Kyverna Therapeutics

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 11 months ago

Funding summaryUpdated 26 Oct 2026

$160Mraised across 2 rounds since 2023, from 2 sources

$60MSeries B$100MRound
Latest round
Round, $100MDec 2025
Step-upi
1.7×
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20242025
$60MSeries B$100MRound
First round
Series B, $60M
Aug 2023
Biggest round
$100M
Round · Dec 2025
Between rounds
2.3 years
from the last two

The rounds

  1. Dec 2025
    Round$100M1 new2 returning

    Source recorded

  2. Aug 2023
    Series B$60M2 new

    Source recordedSEC filing: $152M sold, first sale Nov 2021

Founders and team

From Kyverna Therapeutics's own website and the SEC filings it signed: 15 on the team.

  • Warner BiddleChief Executive Officer
  • Dan MaziaszChief Business Officer
  • Greg MartiniChief Financial Officer
  • Mayo PujolsChief Technology Officer
  • Nadia DacChief Commercial Officer
  • Ritesh SrivastavaChief Legal and Compliance Officer
  • Christi ShawExecutive Chairperson
  • Mert AktarIndependent Director
  • Sravan K. EmanyIndependent Director
  • Dominic BorieExecutive Officeri
  • Ian ClarkIndependent Director
  • James ChungExecutive Officeri
  • Karen WalkerExecutive Officeri
  • Peter MaagExecutive Officer, Directori
  • Ryan JonesExecutive Officeri

On the board, as filediBeth SpiegelmanBrian KotzinDan SpiegelmanFred CohenSteve Liapis

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Insight PartnersVC firm2rounds
RTW Investments LLCGrowth equity2rounds
Bain Capital Life SciencesPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Kyverna Therapeutics

Who invested in Kyverna Therapeutics?

Kyverna Therapeutics's investors include Insight Partners, RTW Investments LLC and Bain Capital Life Sciences.

How much has Kyverna Therapeutics raised?

Kyverna Therapeutics has raised $160M across 2 rounds since 2023.

When did Kyverna Therapeutics last raise?

Kyverna Therapeutics's most recent round was an Undisclosed round of $100M in Dec 2025.

What was Kyverna Therapeutics's biggest round?

Its most recent round, $100M in Dec 2025, is also its largest on record.

Who backed Kyverna Therapeutics first?

Kyverna Therapeutics's first round on record, in Aug 2023, was backed by Insight Partners and RTW Investments LLC.

What stage is Kyverna Therapeutics at?

Kyverna Therapeutics's latest named round is an Undisclosed round, in Dec 2025.

Where is Kyverna Therapeutics based?

Kyverna Therapeutics is based in the United States.

Companies like Kyverna Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.